Patents by Inventor Stanford Moran

Stanford Moran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating hepatitis C virus with omega interferon
    Patent number: 7727519
    Abstract: Methods for the treatment of interferon-response disorders by administration of an interferon alone or in combination with adjunctive therapy are described. The invention encompasses providing to a patient both a formulation of an interferon that is suitable for short-term administration and a formulation of an interferon associated with a sustained release delivery system that is suitable for long-term administration. A principal advantage of the method is that responsiveness to treatment can be ascertained with short-term dosimetric techniques using one formulation of an interferon, which permits the appropriate selection of a dose that is both effective and safe for long-term administration using the second formulation.
    Type: Grant
    Filed: November 5, 2004
    Date of Patent: June 1, 2010
    Assignee: Intarcia Therapeutics, Inc.
    Inventor: Mark Stanford Moran
  • Combination therapy for the treatment of estrogen-sensitive disease
    Publication number: 20050228053
    Abstract: The present invention provides methods which increase the effectiveness of combination drug therapies for treating estrogen-sensitive diseases, such as breast cancer, as well as novel combinations useful to treat such diseases.
    Type: Application
    Filed: June 3, 2005
    Publication date: October 13, 2005
    Inventors: Stanford Moran, Peter Langecker
  • Method for short-term and long-term drug dosimetry
    Publication number: 20050201980
    Abstract: Methods for the treatment of interferon-response disorders by administration of an interferon alone or in combination with adjunctive therapy are described. The invention encompasses providing to a patient both a formulation of an interferon that is suitable for short-term administration and a formulation of an interferon associated with a sustained release delivery system that is suitable for long-term administration. A principal advantage of the method is that responsiveness to treatment can be ascertained with short-term dosimetric techniques using one formulation of an interferon, which permits the appropriate selection of a dose that is both effective and safe for long-term administration using the second formulation.
    Type: Application
    Filed: November 5, 2004
    Publication date: September 15, 2005
    Inventor: Stanford Moran
  • Method for short-term and long-term drug dosimetry
    Publication number: 20050191275
    Abstract: Methods for the treatment of interferon-response disorders by administration of an interferon alone or in combination with adjunctive therapy are described. The invention encompasses providing to a patient both a formulation of an interferon that is suitable for short-term administration and a formulation of an interferon associated with a sustained release delivery system that is suitable for long-term administration. A principal advantage of the method is that responsiveness to treatment can be ascertained with short-term dosimetric techniques using one formulation of an interferon, which permits the appropriate selection of a dose that is both effective and safe for long-term administration using the second formulation.
    Type: Application
    Filed: November 5, 2004
    Publication date: September 1, 2005
    Inventor: Stanford Moran
  • Combination therapy for the treatment of estrogen-sensitive disease
    Publication number: 20050176691
    Abstract: The present invention provides methods which increase the effectiveness of combination drug therapies for treating estrogen-sensitive diseases, such as breast cancer, as well as novel combinations useful to treat such diseases.
    Type: Application
    Filed: November 5, 2004
    Publication date: August 11, 2005
    Inventors: Stanford Moran, Peter Langecker
  • Combination therapy for the treatment of estrogen-sensitive disease
    Publication number: 20050130945
    Abstract: The present invention provides methods which increase the effectiveness of combination drug therapies for treating estrogen-sensitive diseases, such as breast cancer, as well as novel combinations useful to treat such diseases.
    Type: Application
    Filed: November 5, 2004
    Publication date: June 16, 2005
    Inventors: Stanford Moran, Peter Langecker
  • Combination therapy for the treatment of estrogen-sensitive disease
    Publication number: 20020119502
    Abstract: The present invention provides methods which increase the effectiveness of combination drug therapies for treating estrogen-sensitive diseases, such as breast cancer, as well as novel combinations useful to treat such diseases.
    Type: Application
    Filed: October 3, 2001
    Publication date: August 29, 2002
    Inventors: Mark Stanford Moran, Peter J. Langecker